SymBio Pharmaceuticals Limited (TYO:4582)
Japan · Delayed Price · Currency is JPY 65.00
-1.00 (-1.52%)
Aug 21, 2026, 3:30 PM JST
SymBio Pharmaceuticals Cash Flow Statement
Financials in millions JPY. Fiscal year is January - December.
Millions JPY. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -5,992 | -4,748 | -3,806 | -1,195 | 2,106 | 2,032 |
Depreciation & Amortization | - | - | - | 98 | 99 | 93.96 |
Other Amortization | - | - | - | - | - | 1.95 |
Loss (Gain) From Sale of Assets | 86 | 109 | 131 | 568 | - | 0.69 |
Stock-Based Compensation | - | - | - | - | - | 124.27 |
Other Operating Activities | 14 | 2 | 27 | -377 | -420 | -1,048 |
Change in Accounts Receivable | 54 | 163 | 489 | 1,171 | 62 | -1,741 |
Change in Inventory | 123 | -50 | 54 | 237 | -82 | 559.24 |
Change in Accounts Payable | 1,139 | -169 | -215 | -356 | 662 | -595.78 |
Change in Other Net Operating Assets | 37 | 118 | -96 | -340 | -813 | 711.88 |
Operating Cash Flow | -4,539 | -4,575 | -3,416 | -194 | 1,614 | 140.04 |
Operating Cash Flow Growth | - | - | - | - | 1052.51% | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | - | - | -19 | -204 | -2 | -25.45 |
Sale (Purchase) of Intangibles | -82 | -82 | -27 | -28 | -45 | -38.38 |
Other Investing Activities | 1 | 7 | 43 | -144 | - | -7.01 |
Investing Cash Flow | -81 | -75 | -3 | -376 | -47 | -70.85 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | - | 2,924 | - | - | - | - |
Long-Term Debt Repaid | - | -552 | - | - | - | - |
Net Debt Issued (Repaid) | 12 | 2,372 | - | - | - | - |
Issuance of Common Stock | 2,468 | 1,249 | 709 | 681 | 630 | 0.9 |
Repurchase of Common Stock | - | - | - | - | -2 | -68.83 |
Other Financing Activities | - | - | -1 | -1 | -1 | -4 |
Financing Cash Flow | 2,480 | 3,621 | 708 | 680 | 627 | -71.92 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | 64 | -50 | 158 | 125 | 213 | 14.21 |
Miscellaneous Cash Flow Adjustments | -1 | -1 | - | -1 | 14 | - |
Net Cash Flow | -2,077 | -1,080 | -2,553 | 234 | 2,421 | 11.48 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -4,539 | -4,575 | -3,435 | -398 | 1,612 | 114.59 |
Free Cash Flow Growth | - | - | - | - | 1306.78% | - |
Free Cash Flow Margin | -401.68% | -350.04% | -140.09% | -7.12% | 16.11% | 1.39% |
Free Cash Flow Per Share | -73.48 | -91.11 | -76.17 | -9.97 | 40.70 | 2.95 |
Levered Free Cash Flow | -2,492 | -3,089 | -2,055 | -143.5 | 1,542 | -226.95 |
Unlevered Free Cash Flow | -2,446 | -2,996 | -2,055 | -143.5 | 1,542 | -226.95 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 35 | 39 | - | - | - | - |
Cash Income Tax Paid | 3 | 12 | -39 | 354 | 363 | 3.8 |
Change in Working Capital | 1,353 | 62 | 232 | 712 | -171 | -1,065 |